248 related articles for article (PubMed ID: 32208047)
1. Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes.
Beebe-Dimmer JL; Kapron AL; Fraser AM; Smith KR; Cooney KA
J Clin Oncol; 2020 Jun; 38(16):1807-1813. PubMed ID: 32208047
[TBL] [Abstract][Full Text] [Related]
2. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
Menko FH; Ter Stege JA; van der Kolk LE; Jeanson KN; Schats W; Moha DA; Bleiker EMA
Fam Cancer; 2019 Jan; 18(1):127-135. PubMed ID: 29846880
[TBL] [Abstract][Full Text] [Related]
3. Germline mutation prevalence in individuals with pancreatic cancer and a history of previous malignancy.
Dudley B; Karloski E; Monzon FA; Singhi AD; Lincoln SE; Bahary N; Brand RE
Cancer; 2018 Apr; 124(8):1691-1700. PubMed ID: 29360161
[TBL] [Abstract][Full Text] [Related]
4. Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History.
Patel AP; Wang M; Fahed AC; Mason-Suares H; Brockman D; Pelletier R; Amr S; Machini K; Hawley M; Witkowski L; Koch C; Philippakis A; Cassa CA; Ellinor PT; Kathiresan S; Ng K; Lebo M; Khera AV
JAMA Netw Open; 2020 Apr; 3(4):e203959. PubMed ID: 32347951
[TBL] [Abstract][Full Text] [Related]
5. Ovarian Cancer in Hereditary Cancer Susceptibility Syndromes.
Nakonechny QB; Gilks CB
Surg Pathol Clin; 2016 Jun; 9(2):189-99. PubMed ID: 27241103
[TBL] [Abstract][Full Text] [Related]
6. Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing.
Greenberg S; Buys SS; Edwards SL; Espinel W; Fraser A; Gammon A; Hafen B; Herget KA; Kohlmann W; Roundy C; Sweeney C
Cancer Med; 2019 Nov; 8(15):6789-6798. PubMed ID: 31531966
[TBL] [Abstract][Full Text] [Related]
7. Population genetic screening efficiently identifies carriers of autosomal dominant diseases.
Grzymski JJ; Elhanan G; Morales Rosado JA; Smith E; Schlauch KA; Read R; Rowan C; Slotnick N; Dabe S; Metcalf WJ; Lipp B; Reed H; Sharma L; Levin E; Kao J; Rashkin M; Bowes J; Dunaway K; Slonim A; Washington N; Ferber M; Bolze A; Lu JT
Nat Med; 2020 Aug; 26(8):1235-1239. PubMed ID: 32719484
[TBL] [Abstract][Full Text] [Related]
8. Familial Burden and Other Clinical Factors Associated With Various Types of Cancer in Individuals With Lynch Syndrome.
Biller LH; Horiguchi M; Uno H; Ukaegbu C; Syngal S; Yurgelun MB
Gastroenterology; 2021 Jul; 161(1):143-150.e4. PubMed ID: 33794268
[TBL] [Abstract][Full Text] [Related]
9. Singapore Cancer Network (SCAN) Guidelines for Referral for Genetic Evaluation of Common Hereditary Cancer Syndromes.
Singapore Cancer Network (SCAN) Cancer Genetics Workgroup
Ann Acad Med Singap; 2015 Oct; 44(10):492-510. PubMed ID: 26763067
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
11. Risk of cancer in relatives of prostate cancer probands.
Isaacs SD; Kiemeney LA; Baffoe-Bonnie A; Beaty TH; Walsh PC
J Natl Cancer Inst; 1995 Jul; 87(13):991-6. PubMed ID: 7629886
[TBL] [Abstract][Full Text] [Related]
12. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
[TBL] [Abstract][Full Text] [Related]
13. Aligning policy to promote cascade genetic screening for prevention and early diagnosis of heritable diseases.
George R; Kovak K; Cox SL
J Genet Couns; 2015 Jun; 24(3):388-99. PubMed ID: 25577298
[TBL] [Abstract][Full Text] [Related]
14. The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisited.
Cremers RG; Aben KK; van Oort IM; Sedelaar JP; Vasen HF; Vermeulen SH; Kiemeney LA
Prostate; 2016 Jul; 76(10):897-904. PubMed ID: 26989049
[TBL] [Abstract][Full Text] [Related]
15. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
Schofield L; Goldblatt J; Iacopetta B
Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
[TBL] [Abstract][Full Text] [Related]
16. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
[TBL] [Abstract][Full Text] [Related]
17. Patients Tested at a Laboratory for Hereditary Cancer Syndromes Show an Overlap for Multiple Syndromes in Their Personal and Familial Cancer Histories.
Saam J; Arnell C; Theisen A; Moyes K; Marino I; Roundy KM; Wenstrup RJ
Oncology; 2015; 89(5):288-93. PubMed ID: 26315041
[TBL] [Abstract][Full Text] [Related]
18. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
19. Cancer Risk in Families Fulfilling the Amsterdam Criteria for Lynch Syndrome.
Samadder NJ; Smith KR; Wong J; Thomas A; Hanson H; Boucher K; Kopituch C; Cannon-Albright LA; Burt RW; Curtin K
JAMA Oncol; 2017 Dec; 3(12):1697-1701. PubMed ID: 28772302
[TBL] [Abstract][Full Text] [Related]
20. Genetic testing in families with hereditary colorectal cancer in British Columbia and Yukon: a retrospective cross-sectional analysis.
Beard VK; Bedard AC; Nuk J; Lee PWC; Hong Q; Bedard JEJ; Sun S; Schrader KA
CMAJ Open; 2020; 8(4):E637-E642. PubMed ID: 33077534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]